[Paris, FR] Lessons in Herding Cats: Business Development Basics for Life Science Companies

Add this event to your calendar:
21/09/2017 21:00 21/09/2017 23:00 Europe/Paris [Paris, FR] Lessons in Herding Cats: Business Development Basics for Life Science Companies USINE IO , , , Paris 75013 Johnson & Johnson Innovation, JLABS false DD/MM/YYYY

[Paris, FR] Lessons in Herding Cats: Business Development Basics for Life Science Companies

USINE IO , , , Paris 75013

September 21, 2017 from 21:00 PM to 23:00 PM (CET)

$10 - $35

JLABS SAN DIEGO EVENTThe business development professional's purpose is to optimize optionality and long term value at each stage of a company's life. As a company grows and gains traction, it's easy to get enticed and overwhelmed by the numerous opportunities that arise. How do you determine the direction that will add the most value to your company? How do you avoid the constant pursuit of "shiny objects?" How do you know when it's the right time for a strategic partnership?

In this workshop, you'll learn fundamental business development skills to help you successfully evaluate and manage strategic alliances and other potential growth opportunities.

Topics will include:

  • Strategic alliance process management
  • Concepts in valuation
  • Importance of IP and IP diligence
  • Communication and negotiation skills
  • Basic components of a contract

This workshop is geared towards business development professionals and management teams of life science startups.

19:00 | Registration Opens and Networking (Light Food & Beverages)
19:30 | Presentations and Q&A
21:00 | Programme Close

Speaker's Biography:
Heather Roxborough, PhD | Senior Director, New Ventures & Transactions, Consumer, Johnson & Johnson Innovation
Heather is Senior Director of New Ventures & Transactions at Johnson & Johnson Innovation, London, where she is responsible for identifying and transacting on transformational innovations within the Consumer sector.   Heather has spent the majority of her career focused on delivering game-changing innovation.  She has over 7 years’ experience in the Venture Capital industry, most recently as Principal at Tate & Lyle Ventures, where she was actively investing in the health & wellness space.  Prior to this, Heather worked for a number of early stage technology funds investing in a broad range of opportunities from consumer healthcare through to diagnostics and digital.  She has held board positions in a variety of start-ups, always assuming a proactive role and working closely with management teams to help define strategy and support the company through to exit.   Heather started her career at Unilever holding a number of innovation roles from new product development through to corporate venturing and new business creation.  She has a BSc in Biochemistry and PhD in Clinical Biochemistry both from Queen’s University, Belfast.
Connect with Heather: Connect on LinkedIn

Event Partners:


€20 | General Public
€15 | Student/Academic
€30 | At the door

181 rue du Chevaleret
Paris 13e, France

Johnson & Johnson Innovation, JLABS

About Johnson & Johnson Innovation, JLABS Johnson & Johnson Innovation, JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS is open to entrepreneurs across a broad healthcare spectrum including pharmaceutical, medical device, consumer and healthtech sectors. The JLABS flagship opened in 2012 in San Diego at Janssen's West Coast Research Center, and since then has grown to ten global locations including the Bay Area, Boston & Lowell, MA, Houston, Toronto, Beerse (Belgium), with New York City, opening in June 2018, and Shanghai in 2019. For more information please visit www.jlabs.jnjinnovation.com or follow @JLABS.

Event contact

Related content